Thrombolex is committed to helping provide a new standard of care for the treatment of arterial and venous thromboembolic (A+VTE) conditions. Discover our innovative approach to treatment with the BASHIR™ Family of Endovascular Catheters.
An Elegant, Novel Solution For Optimal Thrombus Resolution
The Problem Treating A+VTE safely and effectively while minimizing risk, maximizing clot burden resolution, and producing consistent clinical outcomes is of critical importance. Our Solution The unique hybrid mechanism of action of the BASHIR™ family of endovascular catheters allows the use of both mechanical and pharmacological treatment to immediately restore blood flow. This allows for the efficient and safe introduction of thrombolytics to produce positive clinical outcomes.Product Resources
Product Overview • Product Details
Clinical Resources
Clinical Studies • Instructional Videos
Our Company
Our Mission • Our Leadership
Our Family of Catheters
For restoring blood flow in peripheral and pulmonary vessels
The catheter’s expandable infusion basket allows a controlled and selective infusion of physician-specified fluids.
Available in 7F and 8F sizes.
For restoring blood flow within shorter peripheral and pulmonary vessels
The short basket of the S-B catheter allows navigation and implementation in shorter, more tortuous vessels.
Avialable in 7F and 8F sizes.
For restoring blood flow in peripheral vessels with extensive thrombus burden
A family of catheters designed to deliver thrombolytics through the expandable infusion basket and along a segment of the catheter shaft.
–
Dr. Robert Lookstein discusses how the easy-to-use, safe, and reliable BASHIR™ Endovascular Catheter technology fits within the management of acute PE patients in the current climate of healthcare labor and resource shortages during this @pertconsortium webinar recording. Learn how this novel technology and its standardized procedure addresses these problems.
Thrombolex.com #thrombolex ... See MoreSee Less
0 CommentsComment on Facebook
Visit Thrombolex at booth 1306 during SIR to learn more about our 0.035" guidewire compatible BASHIR™ .035 and BASHIR™ S-B .035 Endovascular Catheters for the treatment of acute PE. Join us for a lunch Symposium on 3/24 at 12:10pm where Dr. Robert Lookstein, Dr. John Moriarty, and Dr. Raj Pyne review compelling on-the-table results of treating acute intermediate-risk PE patients with the BASHIR™.035 Endovascular Catheter from the RESCUE II Study.
Thrombolex.com
#Thrombolex #SIR24 ... See MoreSee Less
0 CommentsComment on Facebook
Thank you to the American Venous Forum for another informative educational event. For more information regarding Thrombolex's unique offering of endovascular catheters, visit Thrombolex.#thrombolexb#venous2024S2024 ... See MoreSee Less
0 CommentsComment on Facebook
Dr. Robert Lookstein discusses how the BASHIR™ Endovascular Catheter is ushering in a “new era” in treating PE and where this novel technology fits into the current PE treatment paradigm. He also covers risk stratification and reviews current treatment guidelines during this @pertconsortium webinar recording.
Thrombolex.com #Thrombolex ... See MoreSee Less
0 CommentsComment on Facebook
Join us today at booth 23 at the American Venous Forum to learn more about the new 0.035" guidewire compatible BASHIR™ .035 and BASHIR™ S-B .035 Endovascular Catheters.
Thrombolex.com
#Thrombolex #VENOUS2024 ... See MoreSee Less
0 CommentsComment on Facebook
What are you missing in your PERT program? Learn how you can do more for your patients when treating acute PE with a safe, clinically proven catheter that delivers superior efficacy while reducing procedure time with the BASHIR™ .035 and BASHIR™ S-B .035 Endovascular Catheters.
Thrombolex.com ... See MoreSee Less
0 CommentsComment on Facebook